The global auto-injectors market is expected to grow rapidly globally, reaching a projected value of USD 67,200.1 million by 2033. Strong 8.2% compound annual growth rate (CAGR) from its 2023 value accounts for this considerable gain. Self-administered medical devices called auto-injectors are designed to deliver a single dose of a certain drug. Typically, long-term conditions like allergies, autoimmune diseases, and severe allergic …
Tag Archives: Auto-Injectors Market
Global Auto-Injectors Market Expected to Reach US$ 67,200.1 Million by 2033, Driven by Rising Demand and Technological Advancements
The global auto-injectors market is experiencing a surge in demand, with a projected value of US$ 67,200.1 million by 2033, reflecting a healthy Compound Annual Growth Rate (CAGR) of 8.2% from 2023. This growth is attributed to several key factors: Increasing Prevalence of Allergies and Chronic Diseases: Rising awareness of allergies and chronic conditions like diabetes …
Auto-Injectors Market Projected to Surge to US$ 67,200.1 Million Valuation by 2033, Fueling Innovation in Healthcare Delivery
In 2023, the global auto-injectors market size is poised to attain a significant valuation of US$ 30,578.2 million, firmly establishing its presence within the healthcare landscape. Yet, what truly captures the attention of industry experts is the remarkable growth trajectory predicted for the next decade. By 2033, projections soar to an impressive US$ 67,200.1 million, …
Auto Injectors Market Status and Prospects 2022 to 2032 | By Sanofi, Pfizer, Inc, Mylan N.V., Novartis AG, Bayer AG
The global Auto Injectors Market size is anticipated to be worth US$ 23.9 billion by 2032, growing at a fantastic compound annual growth rate (CAGR) of 21.4% between 2022 and 2032. In 2022, the market was estimated to be worth roughly US$ 3.5 billion. The increasing frequency of several diseases, such as diabetes, anaphylaxis, and …